CXCL8 and COVID-19: However, it should be noted that PF-4, LF, IL-8 (CXCL8), and polyarginine neutralize the anticoagulant activity of heparin (Shute et al., 2018), particularly in COVID-19 patients associated with thrombocytopenia and LF and IL-8 upregulation.